Abbott Laboratories (NYSE:ABT)
| 113.26 Delayed Data As of May 20 |  +0.82 / +0.73%Today’s Change | 104.63 Today|||52-Week Range 142.60 | -19.53% Year-to-Date |
Latest ABT News | Press Releases
Today’s Trading
| Previous close | 112.44 |
| Today’s open | 113.50 |
| Day’s range | 110.83 - 113.74 |
| Volume | 4,509,572 |
| Average volume (3 months) | 6,038,177 |
| Market cap | $198.3B |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | +57.26% |
| Earnings growth (this year) | -6.39% |
| Earnings growth (next 5 years) | +3.80% |
| Revenue growth (last year) | +24.47% |
| P/E ratio | 26.3 |
| Price/Sales | 5.85 |
| Price/Book | 5.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | +1.10 | +0.44% |
| BSXBoston Scientific Co... | -0.27 | -0.68% |
| BAXBaxter International... | +0.63 | +0.87% |
| DXCMDexcom Inc | +5.03 | +1.59% |
Data as of 4:35pm ET, 05/20/2022
Financials
| Next reporting date | July 21, 2022 |
| EPS forecast (this quarter) | $1.12 |
| Annual revenue (last year) | $43.1B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 16.35% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
